Business
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement outlining its opposition of the proposed acquisition of STAAR by Alcon Inc. ("Alcon") (NYSE: ALC):
About this update from Alcon Ag
[{"type":"text","content":"CHARLOTTE, N.C., Oct. 7, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement outlining its opposition of the proposed acquisition of STAAR by Alcon Inc. ("Alcon") (NYSE: ALC):","length":435,"tagName":"p"},{"type":"text","content":"We have been significant STAAR shareholders for more than ten years and remain convicted in the significant value of the Company. The proposed sale of STAAR to Alcon for $28 per share significantly undervalues the Company, especially when considering the STAAR Board of Directors' rejection of Alcon's previous offer for $58 per share in cash only sixteen months ago.","length":375,"tagName":"p","attribs":{}},{"type":"text","content":"With recent positive projections and outlook released by management, we see no compelling reason to sell STAAR at this time. We are disappointed that the Board has pursued this ill-advised transaction at a valuation that does not reflect the prospects of STAAR's business as a standalone company.","length":300,"tagName":"p","attribs":{}},{"type":"text","content":"About","length":5,"tagName":"p"},{"type":"text","content":"Defender Capital, an SEC-Registered Investment Advisor, manages investment accounts – retirement accounts, non-retirement accounts, trusts, corporate accounts, donor-advised funds, etc. – for individuals, families, and corporations. We take a research driven, long-term approach, investing in U.S. equities.","length":307,"tagName":"p"},{"type":"text","content":"Contacts","length":8,"tagName":"p"},{"type":"text","content":"ASC AdvisorsTaylor [email protected] 992 1230","length":67,"tagName":"p"},{"type":"image","alt":"Cision","displaySize":"","headline":null,"caption":"Cision","className":"","disableSlideshowImg":false,"size":{"original":{"width":16,"height":16,"url":"https://media.zenfs.com/en/prnewswire.com/329b8d3d06131381a29020330af4eb61"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ARkN9w0GsWFJpm8cdrUxuw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2O2g9MzY7Y2Y9d2VicA--/https://media.zenfs.com/en/prnewswire.com/329b8d3d06131381a29020330af4eb61","width":16,"height":16}}},{"type":...